Cargando…

Managing severe tuberculosis and its sequelae: from intensive care to surgery and rehabilitation

Multidrug-resistant tuberculosis (MDR-TB) and extensively drug-resistant tuberculosis (XDR-TB) continue to challenge physicians and public health specialists. Global treatment outcomes continue to be unsatisfactory, positive outcomes being achieved in only 54% of patients. Overall outcomes are even...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tiberi, Simon, Torrico, Marcela Muñoz, Rahman, Ananna, Krutikov, Maria, Visca, Dina, Silva, Denise Rossato, Kunst, Heinke, Migliori, Giovanni Battista
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedade Brasileira de Pneumologia e Tisiologia 2019
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6733754/ https://www.ncbi.nlm.nih.gov/pubmed/31038649 http://dx.doi.org/10.1590/1806-3713/e20180324

Ejemplares similares

New and repurposed drugs to treat multidrug- and extensively drug-resistant tuberculosis
por: Silva, Denise Rossato, et al.
Publicado: (2018)

Post-tuberculosis lung disease: a comparison of Brazilian, Italian, and Mexican cohorts
por: Silva, Denise Rossato, et al.
Publicado: (2022)

Tuberculosis in the time of COVID-19: quality of life and digital innovation
por: Visca, Dina, et al.
Publicado: (2020)

Tuberculosis, COVID-19 and hospital admission: Consensus on pros and cons based on a review of the evidence
por: Migliori, Giovanni Battista, et al.
Publicado: (2021)

Post-tuberculosis sequelae and their socioeconomic consequences: worth investigating
por: Sotgiu, Giovanni, et al.
Publicado: (2021)

Screening for tuberculosis among high-risk groups attending London emergency departments: a prospective observational study
por: Gupta, Rishi K., et al.
Publicado: (2021)

Breathing Back Better! A State of the Art on the Benefits of Functional Evaluation and Rehabilitation of Post-Tuberculosis and Post-COVID Lungs
por: Pontali, Emanuele, et al.
Publicado: (2022)

Is there a rationale for pulmonary rehabilitation following successful chemotherapy for tuberculosis?
por: Muñoz-Torrico, Marcela, et al.
Publicado: (2016)

Tuberculosis elimination: where are we now?
por: Matteelli, Alberto, et al.
Publicado: (2018)

Tuberculosis series 2020
por: Silva, Denise Rossato, et al.
Publicado: (2020)

Tuberculosis series 2019
por: Silva, Denise Rossato, et al.
Publicado: (2019)

Tuberculosis Series 2021
por: Silva, Denise Rossato, et al.
Publicado: (2021)

Shortened tuberculosis treatment regimens: what is new?
por: Silva, Denise Rossato, et al.
Publicado: (2020)

Diagnosis and management of post-tuberculosis lung disease
por: Silva, Denise Rossato, et al.
Publicado: (2023)

Effects of COVID-19 on tuberculosis control: past, present, and future
por: Silva, Denise Rossato, et al.
Publicado: (2022)

Management and outcomes of severe childhood tuberculosis in the pediatric intensive care setting: can we identify best practices?
por: Velizarova, Svetlana, et al.
Publicado: (2019)

Time course of exercise capacity in patients recovering from COVID-19-associated pneumonia. Authors’ reply
por: Zampogna, Elisabetta, et al.
Publicado: (2021)

Tuberculosis series
por: Silva, Denise Rossato, et al.
Publicado: (2018)

International collaboration among medical societies is an effective way to boost Latin American production of articles on tuberculosis
por: Migliori, Giovanni Battista, et al.
Publicado: (2019)

Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases
por: Tadolini, Marina, et al.
Publicado: (2020)

Pulmonary tuberculosis in intensive care setting, with a focus on the use of severity scores, a multinational collaborative systematic review
por: Galvin, J., et al.
Publicado: (2022)

Global TB Network: working together to eliminate tuberculosis
por: Silva, Denise Rossato, et al.
Publicado: (2018)

Delamanid-containing regimens and multidrug-resistant tuberculosis: A systematic review and meta-analysis
por: Nasiri, Mohammad Javad, et al.
Publicado: (2022)

Carbapenems to Treat Multidrug and Extensively Drug-Resistant Tuberculosis: A Systematic Review
por: Sotgiu, Giovanni, et al.
Publicado: (2016)

Migration and medical screening for tuberculosis
por: Silva, Denise Rossato, et al.
Publicado: (2023)

Combined Use of Delamanid and Bedaquiline to Treat Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis: A Systematic Review
por: Migliori, Giovanni Battista, et al.
Publicado: (2017)

Eliminating tuberculosis in Latin America: making it the point
por: Duarte, Raquel, et al.
Publicado: (2018)

Tuberculosis and COVID-19, the new cursed duet: what differs between Brazil and Europe?
por: Silva, Denise Rossato, et al.
Publicado: (2021)

First case of extensively drug-resistant tuberculosis treated with both delamanid and bedaquiline
por: Tadolini, Marina, et al.
Publicado: (2016)

On tuberculosis and COVID-19 co-infection
por: Tadolini, Marina, et al.
Publicado: (2020)

Prospective evaluation of improving fluoroquinolone exposure using centralised therapeutic drug monitoring (TDM) in patients with tuberculosis (PERFECT): a study protocol of a prospective multicentre cohort study
por: van den Elsen, Simone HJ, et al.
Publicado: (2020)

Bedaquiline Phenotypic and Genotypic Susceptibility Testing, Work in Progress!
por: Tiberi, Simon, et al.
Publicado: (2018)

COVID-19 Hampered Diagnosis of TB Infection in France, Italy, Spain and the United Kingdom
por: García-García, José-María, et al.
Publicado: (2022)

Exploring a combined biomarker for tuberculosis treatment response: protocol for a prospective observational cohort study
por: Kloprogge, Frank, et al.
Publicado: (2021)

Screening for Tuberculosis in Migrants: A Survey by the Global Tuberculosis Network
por: D’Ambrosio, Lia, et al.
Publicado: (2021)

Accelerating development of new shorter TB treatment regimens in anticipation of a resurgence of multi-drug resistant TB due to the COVID-19 pandemic
por: Tiberi, Simon, et al.
Publicado: (2021)

Integrating Pharmacokinetics and Pharmacodynamics in Operational Research to End Tuberculosis
por: Alffenaar, Jan-Willem C, et al.
Publicado: (2020)

Mycobacterium tuberculosis and Pulmonary Rehabilitation: From Novel Pharmacotherapeutic Approaches to Management of Post-Tuberculosis Sequelae
por: Meca, Andreea-Daniela, et al.
Publicado: (2022)

Country-specific lockdown measures in response to the COVID-19 pandemic and its impact on tuberculosis control: a global study
por: Migliori, Giovanni Battista, et al.
Publicado: (2022)

Regimens to treat multidrug-resistant tuberculosis: past, present and future perspectives
por: Pontali, Emanuele, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_3ovjbrq48rpo8o7cgak1at093l